In Cloning, Will One Person Really Make a Difference?

In just a week, two developments in Washington restored cloning to the very top of the policy agenda in the United States, knocking stem cell research off the perch it had enjoyed--or just endured--for months. On July 31, by a vote of 265 to 162, the House of Representatives passed the Human Cloning Prohibition Act of 2001, a ban on all human cloning, including therapeutic cloning to derive immunologically compatible embryonic stem cells. And on August 7, Severino Antinori, an infertility specia

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

According to reports, eight of the women who have sought out Antinori are from the United Kingdom. In Britain, reproductive cloning will be made illegal when legislation is introduced by the government in the next Parliament. Meanwhile, the Human Fertilisation and Embryology Authority, which licenses embryo research and storage and infertility treatment involving donated gametes, has announced that it would refuse to license any attempt at reproductive cloning. Hence the necessity for an airplane ticket.

Is there anything that can be done about this reproductive tourism? The British Royal Society has called for a worldwide moratorium on reproductive cloning, at least until the risks and possible justifications of the technique are explored fully. But the obstacles in the way of achieving such a moratorium are daunting and most likely insurmountable. There have been rumors that some unnamed Mediterranean country--clearly not his own--has agreed to host Antinori's efforts. And there have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Arlene Judith Klotzko

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours